| Dr John Jay Hagerty, MD | |
|
489 State St, Nicu Professional Services Emmc, Bangor, ME 04401-6616 | |
| (207) 973-8670 | |
| (207) 973-5163 |
| Full Name | Dr John Jay Hagerty |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 489 State St, Bangor, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740211283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 015301 (Maine) | Primary |
| Entity Name | Eastern Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790789147 PECOS PAC ID: 2062315161 Enrollment ID: O20040128000088 |
News Archive
Researchers at the Institute of Industrial Science, The University of Tokyo (UTokyo-IIS) used artificial intelligence to rapidly infer the excited state of electrons in materials.
A process that limits the number of times a cell divides works much differently than had been thought, opening the door to potential new anticancer therapies, researchers at UT Southwestern Medical Center report in the Aug. 7 issue of the journal Cell.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced that investigators at The University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology have initiated a phase 1/2 study combining Syndax's lead product entinostat with lapatinib ditosylate (Tykerb) in patients with locally recurrent or distant relapsed metastatic breast cancer previously treated with trastuzumab (Herceptin).
Even though patients receiving an implantable cardioverter-defibrillator for primary prevention often receive a dual-chamber ICD, an analysis that included more than 32,000 patients receiving an ICD without indications for pacing finds that the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes, according to a study in the May 15 issue of JAMA.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Jay Hagerty, MD 43 Whiting Hill Rd Ste 300, Brewer, ME 04412-1006 Ph: (207) 973-5000 | Dr John Jay Hagerty, MD 489 State St, Nicu Professional Services Emmc, Bangor, ME 04401-6616 Ph: (207) 973-8670 |
News Archive
Researchers at the Institute of Industrial Science, The University of Tokyo (UTokyo-IIS) used artificial intelligence to rapidly infer the excited state of electrons in materials.
A process that limits the number of times a cell divides works much differently than had been thought, opening the door to potential new anticancer therapies, researchers at UT Southwestern Medical Center report in the Aug. 7 issue of the journal Cell.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced that investigators at The University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology have initiated a phase 1/2 study combining Syndax's lead product entinostat with lapatinib ditosylate (Tykerb) in patients with locally recurrent or distant relapsed metastatic breast cancer previously treated with trastuzumab (Herceptin).
Even though patients receiving an implantable cardioverter-defibrillator for primary prevention often receive a dual-chamber ICD, an analysis that included more than 32,000 patients receiving an ICD without indications for pacing finds that the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes, according to a study in the May 15 issue of JAMA.
› Verified 7 days ago
William R Byers, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6 Telcom Dr, Bangor, ME 04401 Phone: 207-947-0147 | |
Chelsea Jean Swandal, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 133 Corporate Dr, Bangor, ME 04401 Phone: 207-941-1155 Fax: 207-945-5063 | |
Dr. Amy J Movius, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7000 Fax: 207-973-5042 | |
Dr. Shannon M Marchegiani, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: Nicu Professional Services, Kelley 6, 489 State Street, Bangor, ME 04401 Phone: 207-973-8670 | |
Annie E Powers, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 6 Telcom Dr Fl 2, Bangor, ME 04401 Phone: 207-947-0147 | |
Paulette Y. Coty, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1068 Union St, Bangor, ME 04401 Phone: 207-947-0147 | |
Anglea C Gilladoga, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 417 State St, Suite 200, Bangor, ME 04401 Phone: 207-942-4108 Fax: 207-973-8817 |